Back
Akari Therapeutics PLC Stock Price Chart
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
AKTX
Akari Therapeutics PLC
Last Price:
$1.30
Seasonality Move:
-5.77%
7 Day Trial
ALL ACCESS PASS
$
7
7 Nuclear Stocks to Buy Before They Surge
Get your report FREE today!-
The current trend is moderately bullish and AKTX is experiencing slight buying pressure.
Akari Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.33 | Buy |
| 20-day SMA: | 1.08 | Buy |
| 50-day SMA: | 1.14 | Buy |
| 200-day SMA: | 2.28 | Sell |
| 8-day EMA: | 1.34 | Buy |
| 20-day EMA: | 1.19 | Buy |
| 50-day EMA: | 1.19 | Buy |
| 200-day EMA: | 1.94 | Sell |
Akari Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.1 | Buy |
| Relative Strength Index (14 RSI): | 67.74 | Buy |
| Chaikin Money Flow: | 6039 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.86 - 1.28) | Buy |
| Bollinger Bands (100): | (0.86 - 1.84) | Buy |
Akari Therapeutics PLC Technical Analysis
| Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Akari Therapeutics PLC Stock
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.46 while AKTX 8-day simple moving average is 1.33, which is a Buy signal.
-
The stock price of AKTX is 1.46 while Akari Therapeutics PLC 20-day SMA is 1.08, which makes it a Buy.
-
Akari Therapeutics PLC 50-day simple moving average is 1.14 while AKTX share price is 1.46, making it a Buy technically.
-
AKTX stock price is 1.46 and Akari Therapeutics PLC 200-day simple moving average is 2.28, creating a Sell signal.
AKTX Technical Analysis vs Fundamental Analysis
Buy
60
Akari Therapeutics PLC (AKTX)
is a Buy
Is Akari Therapeutics PLC a Buy or a Sell?
-
Akari Therapeutics PLC stock is rated a BuyThe current Akari Therapeutics PLC [AKTX] share price is $1.46. The Score for AKTX is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Akari Therapeutics PLC Stock Info
Market Cap:
36.1M
Price in USD:
1.46
Share Volume:
18.1K
Akari Therapeutics PLC 52-Week Range
52-Week High:
4.40
52-Week Low:
0.85
Buy
60
Akari Therapeutics PLC (AKTX)
is a Buy
Akari Therapeutics PLC Share Price Forecast
-
What is the Akari Therapeutics PLC stock price today?The Akari Therapeutics PLC stock price is 1.46 USD today.
-
Will AKTX stock go up or go down?Akari Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Akari Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Akari Therapeutics PLC is not overvalued.
Is Akari Therapeutics PLC Stock a Buy?
-
Akari Therapeutics PLC share price is 1.46 while AKTX 8-day exponential moving average is 1.34, which is a Buy signal.
-
The stock price of AKTX is 1.46 while Akari Therapeutics PLC 20-day EMA is 1.19, which makes it a Buy.
-
Akari Therapeutics PLC 50-day exponential moving average is 1.19 while AKTX share price is 1.46, making it a Buy technically.
-
AKTX stock price is 1.46 and Akari Therapeutics PLC 200-day simple moving average is 1.94, creating a Sell signal.
Technical Analysis of Akari Therapeutics PLC
Should I short Akari Therapeutics PLC stock?
-
AKTX Moving Average Covergence Divergence (MACD) indicator is 0.1, suggesting Akari Therapeutics PLC is a Buy
-
Akari Therapeutics PLC Relative Strength Index (RSI) is 67.74, which suggest Akari Therapeutics PLC is overbought
-
The Bollinger Bands (25) for Akari Therapeutics PLC is (0.86 - 1.28), which suggest Akari Therapeutics PLC is a Buy
-
The Bollinger Bands (100) for Akari Therapeutics PLC is (0.86 - 1.84), which suggest Akari Therapeutics PLC is a Buy
* Akari Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.